ArticleInternational journal of molecular sciences2025

HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and Myeloma.

Elizabeth Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.